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Introduction: Brain neoplasm survival rates have increased substantially in developed 
countries due to modern medical interventions, research, and enhanced therapeutic 
options. As the second leading cause of pediatric cancers, this has been a topic of interest 
within the field of public health. With mortality decreasing, scientists are now focusing 
the lens on the long-term outcomes of survivors, coined “survivorship” and subsequent 
late effects. These effects are the combined neurocognitive, psychological, and social 
deterioration and deficits experienced due to the brain pathology itself or exposure to 
associative treatments. This phenomenon is now appearing frequently in the literature. 
The aim of this review is to examine standards of care, planning for survivors, post-
diagnostic interventions, and lapses in follow-up for brain tumor survivors. Models of 
care were observed in three major hospital systems and compared to the literature. 
Furthermore, a comprehensive examination of common late effects associated with the 
various treatment modalities, and the process for continued patient care has been 
provided for scope. Methods: Relevant literature was derived from publicly available 
databases for scholarly articles. Peer-reviewed studies were slated for consideration. 
Discussion: The extent of neurocognitive, psychological and social decline is individual 
and lapses in care come from lack of standardization in the follow-up process. Also, with 
current models of care, there is a substantial patient initiative is required, leaving patients 
and caretakers, already heavily burdened, to fend for themselves. This review contributes 
to the knowledge base afforded to survivors, thereby informing patients, caregivers, and 
practitioners, such that preemptive decisions can be made to bolster late effects and 





Cancer is a major public health concern. According to the CDC, it is the second 
leading cause of death in the United States, just after heart disease (CDC, 2021). For 
children, brain cancer is the most common, and pediatric brain tumors (PBTs) account for 
most cases of solid cancer in this age category (Satariano, 2016). Due to medical 
developments, interventions, research, and innovative therapeutic options the five-year 
survival rates have increased to around 80% (Lönnerblad et al., 2019). With mortality 
decreasing, scientists and medical professionals are now focusing the lens on the long-
term outcomes of survivors.  
Around 700,000 Americans live with a primary brain tumor, and 85,000 are 
projected to be diagnosed in the coming year (Quick Brain Tumor Facts, 2020). 
Survivors will have been exposed to various treatments, such as chemotherapy, radiation, 
or surgical resection, among other therapeutic options, which all have associative 
hazards. Also, the brain pathology in and of itself can have deleterious effects. 
Researchers are just beginning to understand the role of maladaptive health behaviors, the 
development of psychological conditions, and the interplay of subsequent disease states 
that come after the initial diagnosis. Michael Feuerstein, a cancer survivor, describes this 
experience as such: “There are many unmet needs and concerns of patients and their 
caregivers further complicated by high symptom burden, often at disease onset, which 
increases over time due to tumor, treatment effect, or most often, an admixture of both” 






Late effects  
Late effects are the combined neurocognitive, psychological, and social 
deterioration and/or deficits experienced due to the brain pathology itself or exposure to 
associative treatments. Late effects are highly individual and come with varying ranges of 
severity due to the diverse group of aetiologies, treatment options and subsequent 
modality-specific toxicities, care options, and disease occurrence. While there is no setlist 
of what a patient will experience, there are common problems that have been reported, 
and new connections are coming to light through more research and clinical trials.  
Cognitive impairment is just one of many possible late effects, but 50-90% of 
brain tumor survivors will experience this to some degree (Alemany et al., 2020).  
Cognitive impairment could include the considerable decline in executive functioning, 
attention, working memory, and processing speed. Diminished IQ and mental fatigue are 
also reported (Winter et al., 2014). Fatigue has been associated with other somatic and 
psychological late effects as well. Endocrinopathies and depression, for example, can be 
the culprit. However, fatigue can also display as a stand-alone symptom and manifest as 
concentration problems, irritability, and physical deficits. The interplay of the late effects 
is not well studied but is a valid concern. 
 Problems in the area of executive functioning would include the inability to 
regulate behaviors and exert control, goal setting, and willpower. In a study by Alias et 
al., processing speed has been listed as a “core deficit.” The forfeiture be related to white 




available data were metrics describing the extent of a neuropsychological processing 
deficit which comprised of: “alertness, sustained attention, focused attention, working 
memory capacity, executive visuomotor control, and cognitive flexibility.” Survivors are 
susceptible to distractions, have lower levels of inhibition, and are less alert, which is in 
concurrence to available research (2018). 
The presence of these neurocognitive late effects has been thought to predict 
subsequent psychological and social difficulties. Coping through the lifecycle of 
survivorship has been listed as an essential idea when considering the mitigation of late 
effects and the eventual dilapidation in health. Cognitive impairment and decline in 
executive functioning, as aforementioned, can result in the decline of processing, 
attention, working memory, etc. This is likely to affect the ability of the survivor to 
utilize appropriate coping mechanisms and can consequently exacerbate psychological 
and social effects – the proverbial domino effect. (Robinson et al., 2015). 
The literature is scant on psychological effects experienced by survivors, as few 
studies have truly addressed these effects or focused solely on them. Yet, among the body 
of evidence, these effects are noted across the board. Psychological corollaries 
encompass the mental, emotional, and behavioral aspects of the patient experience and 
regularly overlap with the neurological effects. Likewise, social deficits experienced by 
brain tumor survivors consistently coincide; hence they are often referred to as 
psychosocial effects. Behavioral and emotional regulation are important factors to 
consider as deficits in these areas could affect school and subsequent work performance 
in later years. Hindrances in these settings might mean a limited scope of options for 




From a behavioral standpoint, attention-deficit/hyperactivity disorder (ADHD) is 
prevalent in the survivor population, especially for those diagnosed at a younger age 
(Shabason et al., 2019). Social competence, a facet of self-esteem, has been reported as a 
deficit for PBTS, with anticipated continual decline as the patient ages (Ruiter et al., 
2015). Indications of post-traumatic (PTSD) stress are not uncommon for survivors and 
appear to gradually intensify with age, with 20.5 % of adult survivors meeting the criteria 
for PTSD in one studies sampling, as cited in a study by Cousino et al. (2017). 
Depression, anxiety, and antisocial behavior have all been consistently conveyed 
throughout the trials. Suicide ideation was noted in a study from Cancer Epidemiology, 
with had a reference to the Childhood Cancer Survivor Study (CCSS). Somatization, 
where psychological concerns manifest as organic symptoms, was described in the study 
as well. This phenomenon increases progressively as survivor health deteriorates. Within 
the same study, a cited Swiss Childhood Cancer Survivor Study (SCCSS) listed psychotic 
tendencies and aggression among self-reported late effects, especially prevalent in the 
female survivor population (Erdmann et al., 2020). 
External factors such as family stress, coping, and function seem to play a role in 
the mental and emotional state of the survivors – though adaption related studies are 
insufficient. Competence and attention either by the caregiver or the survivor appear to 
have an effect in the direction of long-term outcomes, which range from positive to 
detrimental (Barakat et al., 2015). Survivors of brain tumors have been found to leave 
their parent homes later, especially males., and there is some evidentiary support for a 
lower likelihood of marriage and cohabitation with a partner. Further, survivors are less 




to psychological late effects, biological repercussions from somatic late effects, fertility 
problems, and concerns about the future (Erdmann et al., 2020) 
These outcomes are often measured through self-reporting or report by proxy, via 
a teacher, parent, caregiver, etc.  Health related quality of life, HRQOL, is a 
comprehensive evaluation that is frequently referred to in the literature. This subjective 
measure looks at illness from a multidimensional perspective noting general, physical, 
spiritual, and social aspects. Other significant features of this assessment are that it looks 
at resilience and body image, which is an often overlooked component of psychological 
health. Another common reported measure is the Intensity of treatment rating, which 
increases based upon treatment type and number of treatment modalities. Supplementary 
objective scales surrounding health and wellbeing are the Bakas Caregiver Outcomes 
Scale (BCOS), Family Assessment Device (FAD), Brief Symptom Inventory (BSI).  
These look at various aspects of social, psychological, and physical functioning to 
provide scope. The Pediatric Oncology Quality of Life Scale looks at HRQOL’s physical 
and emotional components and rates them on a Likert scale, with lower POQOL being 
indicative of high HRQOL (Barakat et al., 2015). 
While most late effects are considered damaging, there are reported measures that 
indicate certain positive outcomes. Resilience is the ability to recover from undesirable 
situations, a measure of grit. This is often increased in survivors. Further, increased social 
connectivity is a consequence of late effects and brain neoplasms in general. This 
“posttraumatic growth,” as it is called, has positive connotations, and increased 
interpersonal relationships, resiliency, spiritual and religious beliefs, body image are 




in social interactions, one study reported friendships as being a motivating factor in 
continuing schooling and work, though there may be difficulties in organizational settings 
due to late effects. An aspect of hopeful future social growth is shown in survivors as 
well (Boydell et al., 2008). 
 Somatic disease burden can manifest in many ways, and these late effects can 
influence any body system. Severity and type appear to have some relation to age at 
clinical onset, anatomical location, presence of secondary tumor, grade, and treatment 
modality than the psychological and social effects. One study by Bhakta et al. found that 
by fifty years of age, survivors suffered up to 17 chronic health conditions, on average 
(Erdmann, 2020). Typically reported sequelae across the board include seizures, 
generally partial complex seizures, and headaches. Physical functioning and athletic 
performance are often at a deficit. Both hearing and vision loss have been included 
among possible neuropathies, as well (Alemany et al., 2020). Among possible visual 
neuropathies is a dysconjugate gaze, a lack of of visual coordination that will affect the 
survivor into adulthood in both the educational setting and in reading tasks (Janss, 
Mazewski, Patterson, 2019). 
 Additionally, endocrine disorders are often diagnosed and well documented 
among survivors. Hypothyroidism, hypogonadism, and hyperprolactinemia are among 
possible late effects. Excess weight and obesity can also present for brain tumor 
survivors, nonspecific to gender (Ramanauskiene et al., 2014). Hypersomnia, sleep 
apnea, and autonomic dysregulation are also possible (Janss, Mazewski, Patterson, 2019). 
Pituitary hormone (PH), Growth hormone (GH), luteinizing hormone (LH), follicle 




also implicated in many survivors. Adrenal axis functioning was often seen as deficient 
and endocrine dysfunction was seen within a decade in one study of a neuro-oncology 
database (Lawson et al., 2019). 
 Endocrinopathies are deleterious and associated with negative prognosis 
including, but not limited to life-long treatment, decreased quality of life, and frequent 
symptom management. Endocrine dysfunctions can take many years to develop after 
initial diagnosis and treatment. Thus, early detection is key to improve morbidity and 
prospective health for survivors. For young children and adolescents, these 
neuroendocrine late effects can adversely affect growth and puberty, with both expedited 
and delayed puberty described in studies. Furthermore, because these disorders can have 
late-onset, they may not be diagnosed right away, as aforementioned, which can have 
long-lasting consequences for patients and higher associative costs for chronic disease 
management (Maciel et al., 2021). It is difficult to discern whether these hormone 
deficiencies are caused by the tumor or the treatment, although they likely have a 
compounding effect, and tumor location appears to play a major role as well across the 
various studies.  
 Metabolic syndromes and complications have also been listed as potential late 
effects. Maciel et al. described impaired cardiac functioning, abnormal lipid profiles, 
higher body fat levels, insulin sensitivity reduction, and atypical glucose tolerance as a 
direct result of hormonal late effects, most notably in GH deficiency. Early-onset 
atherosclerosis and bone density symptomology was also discussed (2021). 
Ramanauskiene et al. similarly show through analysis that cytostatic drugs used in 




promotion of atherosclerotic plaques, atherogenesis. As in the Maciel et al. study 
findings, the group reported dyslipidemia, diabetes, osteoporosis, and hyperinsulinism in 
brain tumor survivors, resulting from treatment and endocrine dysfunction (2014). 
 Other possible somatic late effects have included pulmonary disease. Risk factors 
for pneumonia are higher, and survivors of CNS tumors have the “highest excess risk” 
for respiratory death in the Erdmann et al. epidemiological study. French and British 
Childhood Cancer Survivor Studies, FCCSS and BCCSS respectively, cited within the 
study both indicate diabetes mellitus, as well as difficulties with pregnancy and labor. 
Survivors are also at an increased risk for stroke (2020). 
 The neurocognitive, psychosocial, and somatic late effects described within this 
review are just a sampling of conceivable symptom affliction suffered by patients. The 
breadth of prospective late effects experienced by survivors is extensive and highly 
complicated, as previously stated, but nonetheless a valid statement that bears iteration. 
Deficiencies and dysfunctions frequently take time to develop. Oftentimes, survivors will 
not follow up, even if a late effect is identified (Mellblom et al., 2020). There is a call 
throughout the literature to standardize and structure models of care to better support 
survivors and provide sufficient access to said care programs. For children and 
adolescents, it is suggested that “pedagogical assessment and individualized support” be 
offered, regardless of tumor grade, as it has been determined in studies that brain tumor 
survivors perform at a deficit in the educational setting, irrespective of malignancy, and 




With such noble intentions, these ideas appear to have merit and it is possible that 
educational settings could slate students for supportive care. However, for the average 
adult, past the formative educational years, there is no such system in place to control for 
preemptive screening, cognitive training, and symptom management. Hardly falling 
within recognized traditional company benefit obligation, the responsibility falls to the 
patient and/or caregiver. Moreover, time taken from employment and costs of screening 
outside the educational setting provide another complex set of considerations for the 
brain tumor survivor. Such luxuries are not afforded to all.  
Survivorship 
 In 2006, the Institute of Medicine published a bellwether report: From Cancer 
Patient to Cancer Survivor: Lost in Transition, whereby the idea of “survivorship,” and 
what that meant, began to take a tangible form. The report defines survivorship as a 
“distinct phase of the cancer trajectory,” Providing such designation takes the 
metaphysical ideology of what it means to “survive” and bestows both shape and scope. 
A clear delineation of the term allows for advocacy and awareness. These are essential 
functions in fostering momentum and a trajectory towards a goal, namely individualized 
clinical standards, comprehensive research, and accessible, perpetual coordinated care. 
Furthermore, the report elucidated essential components of what survivorship care is 





Figure 1.  Essential Components of Survivorship Care, as outlined by the Institute of 
Medicine Report, From Cancer Patient to Cancer Survivor: Lost in Transition (2006) 
The authors of this review speculated that care of quality would include these four components 
and imagined a system wherein attention and awareness afforded both providers and patients a 
more complete understanding of late effects, earlier diagnosis, and a plausible detection of trends 
(National Research Council, 2006). 
 
 With the advent of a new survivorship definition, there came a “strong impetus to 
take clinically meaningful steps toward broadening the focus of neuro-oncological care” 
(Leeper, Milbury, 2018). The growing consensus was that there was a need to focus on 
individual patient care plans, as well as an overhaul at the systems level (see Appendix 
A). A model of quality care would take a village, or rather a high qualified, 
interprofessional team that can take the patient from the acute phase at clinical diagnosis, 
through  follow-up, and into long-term management. An identification of the 
“stakeholders” was invaluable to carving out a purposeful plan (National Research 
Council, 2006). In 2012, the American College of Surgeons Commission of Cancer 
(CoC) issued a directive that patients be provided survivorship care plans. This was a 
crude first attempt at standardizing care as outlined by the 2006 report. These early plans 
were to include information surrounding the patient-specific treatment modality and 




primary care physician (PCP) was projected to play a significant role in the early models 
of care as the thruput between necessary intervention and continued management of 
health. Other mid-level were expected to fill in the gaps (Leeper, Milbury, 2018).  
 
RESEARCH STRATEGIES 
 Applicable background information on late effects, the survivorship concept, and 
data surrounding general survivorship programming were derived by conducting a 
systematic review of publicly available databases and search engines for scholarly work, 
including EBSCO host, PubMed, and Google Scholar. The year of publication was noted, 
with newer, pertinent studies taking precedence in the selection of relevant literature. 
Moreover, peer-reviewed articles were slated for consideration as a means of quality 
control to provide rigor to the data and ideas presented herein.  
  Three large hospital systems in Pennsylvania with an associative survivorship 
program were chosen for comparison: University of Pennsylvania Hospital (HUP), 
Thomas Jefferson University Hospital (TJUH), and University of Pittsburgh Medical 
Center (UPMC). The Sidney Kimmel Cancer Center, an Affiliate of Thomas Jefferson 
University Hospitals and Jefferson Health, offered the Neu Center for Supportive 
Medicine and Cancer Survivorship as well as the Brain Tumor Center support group. The 
Abramson Cancer Center is the oncology center for the University of Pennsylvania 
Hospital and has the Abramson Cancer Center Survivorship Program. University of 
Pittsburgh Medical Center is associated with the Hillman Cancer Center and offers the 




Reviews of the various program offerings were completed using information 
available from the relevant group websites and general details through operators of the 
programs. Qualitative assessments of the survivorship plans were made based upon the 
model, perceived efficacy, and consistency of care. Patient follow-up timelines were 
taken into account, with respect to acute phase, just after rendered diagnosis and 
treatment, versus long-term management of care. Coordination of services and 
appointments via a primary care physician, a team, or a nurse navigator was observed.  
Furthermore, attention was paid to the patient and caregiver responsibilities within the 
survivorship planning, as it was perceived to affect compliance with a care plan. 
 
 DISCUSSION 
As illustrated throughout the review, survivorship has become a topic of increased 
interest within the research realm and in the field of public health. For brain cancer 
survivors, the initial assault of diagnosis and treatment are typically just a blip on the 
radar, with the actual battle existing in the future unknown and the array of potential late 
effects. Information is power, and the access to pertinent material surrounding late 
effects, warning signs, supportive care, and mitigation strategies is thought to be the best 
way to bolster survivors for what is to come. Cancer programs, research teams, and major 
hospital systems have begun to implement programs and policies aimed to meet the 
essential components of survivorship care (Figure 1). Care models have been developed 
accordingly in an attempt to meet the various and individual needs of patients and their 




review looks at a comparison between three major hospital systems in Pennsylvania and 
respective survivorship care models.  
Penn Medicine 
The University of Pennsylvania Health System (UPHS), colloquially referred to 
as Penn Medicine, is associated with the Abramson Cancer Center. U.S. News & World 
Report lists it among the top 15 hospitals in the nation and within the top 20 for 
Neurology and Neurosurgery (U.S. News, 2020). As the forerunner in the group to be 
studied, it was initially assumed this system would provide the most thorough and 
comprehensive model. Indeed, upon examination, UPHS had a very well outlined 
program run in large part by nurse navigators who coordinated care and services with 
other providers within the UPHS system. The Abramson Cancer Center interestingly 
boasted the first adult survivorship care program in the nation, founded in 2001. This is 
not insignificant, as most therapeutic interventions, research, and survivorship models 
centered around pediatric tumors and adolescent late effects (Survivorship Program, 
2021). This model had specific teams for cancer type, with a nurse navigator leading each 
team. For neuro-oncology specifically, there is a brain tumor support team and 
integration of services to meet individual needs (Brain Tumor Support, 2021).  
 New patients gain access to the system through a referral from a primary care 
provider, a specialist or can recommend themselves through a call center. Patients could 
include local residents, children aging out of the Children’s Hospital of Philadelphia 
(CHOP – pediatric affiliate of UPHS), or even out-of-state residents willing to pay  out-




assess current state, schedule necessary treatment based upon provider recommendation, 
and then proceed to connect the patient with various subspecialties for continued care. 
Contact is largely achieved through email and phone calls for the convenience of the 
patient and to alleviate the heavy patient load of the navigators. When a patient passes the 
acute phase, which is the immediate diagnosis and treatment, they are slated for follow-
up scans and appointments as recommended by the oncologist and managed care team 
that is part of the patient’s individualized care plan (Brain Tumor Support, 2021). 
Insurance is not likely to be an issue, for if it is accepted once, it will be accepted 
anywhere within UPHS. Due to the extensive network within UPHS, there is no barrier in 
coordination of services in-house, and there is no lack of sub-specialists available to 
provide world-class care.  
 The positive aspects of UPHS speak volumes to the program. The nurse 
navigator’s role coordination of care in the acute phase alleviates patient and caregiver 
burden to a certain degree, which is critical under the duress of the circumstance. The 
broad network of providers and subspecialists means patients can be confident symptoms 
and late effects will be addressed by a highly qualified individual within the system. The 
neuro-oncology brain tumor support team tends to keep patients until the follow-up scans 
trail off, whereupon there is the Survivorship Program, which is available to any adult 
survivor. This program will provide a questionnaire to identify late effects, but again – 
after the presentation. Information and strategies for late effect management are given as 
well, and referrals are made to nutritionists for metabolic complications, therapists, or 
specialists such as an endocrinologist for somatic symptoms. The University of 




trials being conducted with convenient access. Patients can receive information about 
these services through the generalized survivorship program as well, but it is not 
required. Survivors are given a choice to continue coordination with the neuro-oncology 
team (Brain Tumor Support, 2021). 
 The UPHS model of survivorship has good bones. The effort aimed at quality and 
access to care is evident. The scaffolding for a truly efficacious model is present, but 
there are some negative aspects to the UPHS model. For one, navigators make calls to 
patients in the acute phase for coordination of services and treatments. After such time, it 
is the burden of the patient or caregiver to contact the navigator or primary care physician 
for follow-up scans, symptom discussions, and questions about late effects. Doctors may 
or may not have discussions with their patients about late effects, but these tend to 
happen as symptomology presents, meaning there is only secondary or tertiary 
intervention of late effects, at best. There are no prescription services, and the use of the 
navigator or provider to coordinate care does not necessarily ensure a timely visit. 
Patients and caregivers still must wait patiently for appointments, as nothing is expedited 
by virtue of utilizing the survivor care plan. There is also limited capacity, especially for 
psychosocial treatment. Should a patient need more care, there will be a local referral, but 
the responsibility falls to the patient again to set up and manage appointments and 
symptoms. The model is focused more on access for new patients, as opposed to case 
management. There are limited resources and staff, even for such a large system. As 






 Thomas Jefferson University Hospitals (TJUH), or Jefferson Health, is another 
nonprofit organization in the city of Philadelphia. While lacking the ivy name, TJUH has 
no shortage of hospitals, 14 to be specific, and is not lacking in available services for 
brain tumor patients and survivors. In fact, there is a recent merger proposal with Einstein 
Healthcare Network, which would greatly expand the Jefferson services, provide access 
to the underserved populations in the Philadelphia area, and further the interests of 
community health initiatives (Brand, 2021). Within the Jefferson hospital system, there is 
the Sidney Kimmel Cancer Center and the Brain tumor support division. More recently, 
the Neu Center for Supportive Medicine and Cancer Survivorship was founded, but it is 
currently only available at the Center City Campus (Jefferson University Hospitals, 
2021). 
 The Brain Tumor Support Center is facilitated by specialists from the Vickie and 
Jack Farber Institute for Neuroscience, as mentioned in the Support and Resources Tab of 
the Jefferson Hospital webpage. Offerings include a Brain Tumor Support Group every 
second Thursday of the month, where patients and families can attend to receive 
emotional support from other survivors, creating a sense of community. Through the 
Cancer Center are generalized oncology social workers, support groups, and nutrition 
counselors available to patients. Just as with UPHS, there is access to clinical trials and 
research studies, as well as educational opportunities to learn more about brain tumors 
and treatment options. The group also affiliates with the Reproductive Medicine 




Support Center at Jefferson wanted to maintain supportive care options, and so provided 
mindfulness activities to help ensure cancer patients did not feel alone, such as free 
Headspace Application access, guided art, and recorded yoga (Supportive Care for 
Survivors, n.d) 
The Neu Center for Supportive Medicine and Cancer Survivorship offers 
informative services to newly diagnosed patients. Greg Garber, Director of the Cancer 
Support and Welcome Center, explained the program offerings as such: “This can be 
anything from work and family-related issues, to the management of distress and other 
symptoms, education around survivorship-related topics, and guidance on nutrition, 
finances and insurance, sexuality and intimacy, and self-care,” (Supportive Care, n.d.). 
This program aims to specifically address psychosocial late effects in an impactful way. 
The spiritual, psychological, social, and economic needs of survivors and their caregivers 
are taken into consideration. Appropriate counseling and assistance are rendered based 
upon continued evaluation of the survivor population. Garber purported “aggressive” 
management of symptoms in “as many areas as possible” would mean better outcomes 
for survivors (Supportive Care, n.d.). Through the program, there is also the Jefferson 
Buddy Program, that connects patients with a similar diagnosis. 
Positive aspects of the Jefferson Program definitely include the strong 
psychosocial late effect support component. The Neu Center is unique in the rigor of this 
feature, and it can only serve to help survivors better handle late effects as they arise. 
Furthermore, the range of supportive care groups, specific to interventions, and integrated 




Jefferson System. Yoga, meditation applications, and educational services can help 
patients better cope, which is an important facet of survivorship, as previously 
mentioned. Whereas fertility management and aggressive psychosocial late effect 
exploration help mitigate somatic and psychological symptom burden. Moreover, 
research from the current patients allows for further survivor care plan development, as 
this program is in its infancy. This is indicative of better patient outcomes as the program 
matures. 
The Jefferson program attributes are worth noticing. However, there are still 
deficits. For one, the plethora of counselors and the use of the generalized Support and 
Welcome Cancer to get access to the brain tumor-specific services could be confusing for 
survivors. While it may not seem significant, extra calls, more hurdles, and less help 
equal more burden for patients and caregivers, already exhausted mentally, physically, 
and emotionally. Also, there is little information pertaining to the active pursuit of 
patients for supportive follow-up, meaning they likely fall through the cracks, just as with 
UPHS.  
UPMC 
The University of Pittsburgh Medical Center, or UPMC, is a mammoth nonprofit 
healthcare organization on the western side of Pennsylvania, with satellite locations 
nestled all over Pittsburgh. U.S. News & World Report lists UPMC Presbyterian 
Shadyside as the number two hospital in Pennsylvania, above TJUH, and just behind 
UPHS, which holds the coveted first place position (U.S. News &World Report, 2021). 




United States Census Bureau, with some 300, 286 residents. The lack of ethnic diversity 
is a point of interest, excepting a larger Hispanic population than Philadelphia. Education 
and cost of living, and availability of housing are higher for Pittsburgh, too. This means 
the health landscape of the city looks different, based upon the social determinants of 
health (Quickfacts, 2019). Suffice it to say, UPMC serves a vastly different population 
with different sets of needs. However, the system is equally matched in neurosurgery and 
neurology, just neck-and-neck with the University of Pennsylvania Hospital System for 
rankings.  
UPMC offers the Hillman Cancer Center and the Cancer LiveWell Survivorship 
Program to address late effects and patient requirements throughout the life cycle as a 
survivor. According to the available data: “Our goal is to make cancer survivorship as 
easy as possible by addressing a wide range of needs and concerns” (Survivorship 
Program, n.d.). Just as with TJUH and UPHS, the LiveWell program grants patients 
access to clinical trials and participation information for research studies, support group 
connections, and newsletters. The rest of the services are aimed to augment current and 
prescribed care. Consults are offered with midlevel providers upon treatment completion. 
The website lists coordination of care as a possible service to integrate future care with 
the doctor’s therapeutic forecast. Observation for reoccurrence is assured, and 
management of both short- and long-term effects is mentioned but not explicitly stated. 
Genetic counseling, fertility services, nutrition, and rehabilitative services are available at 




 As with the other programs, the UPMC model of survivorship care seeks to 
address late effects and help provide services surrounding treatment become a reality 
through care coordination in the acute phase. The website outlines these services in no 
specific terms but asserts the provider consults would manage follow-up care. With 
nutritional, fertility, and genetic counseling options, UMPC is up to date with competitors 
in provisional tools available to survivors, too. The hospital system is diverse, so 
availability of practitioners is not a problem, nor is accessing services, provided the 
insurance was accepted upon treatment. Similar to the case with UPHS. Patients have a 
plethora of specialists to choose from but must wait for appointments, as with UPHS.  
The biggest pitfall to the UPMC LiveWell program is, again, the patient/caregiver 
incumbrance to coordinate. Even accessing the initial coordination services must fall to 
the patient or caregiver after a doctor has given a referral. Symptoms are addressed as 
they come about with providers, not before, and that does not necessarily mean a call to 
the program will be made. Primary care physicians and specialists make 
recommendations, and it is up to the patient to follow up. Also, the generalized nature of 
cancer services is less targeted than the Jefferson or Penn models. Brain tumor survivors 
are afforded more individualized care through the lifecycle of the Philadelphia brain 
tumor survivor-specific programs.  
A Utopian Model of Survivorship 
 From the comparison, it can be discerned that the three systems had three vastly 
different programs, despite all working towards the collective goal of quality care, tailored 




eyesore in each of the presented programs was the responsibility placed on patients and 
caregivers to access services. This hardly seems reasonable, considering the constraints 
and stress a patient and their loved ones are already experiencing just by virtue of diagnosis 
and subsequent treatment.  
The lack of available professionals to ensure adequate follow up is understandably 
a cause for concern. Mid-level providers play an important role, bridging the gaps and 
alleviating the strain on primary care and specialist services, and navigating follow up. 
UPHS does this best with the nurse navigator system. The other two models make some 
effort to coordinate between the specialist treatment plan and the primary care providers. 
Still, the outline of these models in action was vague, fragmented, and vapid in approach. 
The previously mentioned Institute of Medicine Report, describes this as an “absence of a 
locus of responsibility” (National Research Council, 2006). When there aren’t enough 
nurses and navigators, the responsibility shifts to caregivers and patients. This is 
inappropriate and irresponsible from an ethical standpoint.  
A proposed survivorship model would feature end-to-end integration of services. 
See Appendix A for a process flow diagram depicting an example of a proposed survivor 
care model. A streamlined, standardized process where survivors and caregivers take a 
back-seat approach and follow along for the journey would be the gold standard. Specialists 
and primary care providers would sit at the forefront, determining treatment modalities and 
individualized follow-up plans based on clinical diagnosis, treatment type, and patient 
history. Future scanning and primary care visits would have an outlined schedule that could 




coordination of care, including scheduling scans, services, prescriptions, and late effect 
tracking. A system like this would require advanced record keeping, registry-based 
systems, and separate systems to keep track of all patients, such that no patient is left 
behind.  
Much of the literature cited the importance of preventative care. For neurocognitive 
and psychosocial late effects, this includes catching symptoms early for a better prognosis. 
In an ideal model, all patients undergoing treatment would receive supportive services 
throughout the acute phase and then receive a baseline assessment upon entering into a 
survivorship program. Best practices would dictate each patient be assigned a counselor or 
social worker, along with the nurse navigator, who could see the patient, caregiver, and 
family through the next phases of care.  Patient fears and concerns would need to be 
assessed and periodically addressed through virtual health sessions, visits, surveys, phone 
calls, or emails. It would fall to the social worker to document, record, and relay any 
concerns to the primary care physician or nurse navigator for follow up, and it would be 
the job of the liaison to continue to check-in.  
Speech, occupational and physical therapy baseline assessments could be made 
upon entrance into the survivorship program. Furthermore, it would be useful to garner a 
baseline for genetic, fertility, and nutrition as well. Late effect deficiencies in these areas 
are well known, which is why most programs offer services for them. The best model 
screens late effects habitually. Supportive psychosocial services, neurocognitive testing, 
screening for various somatic and psychological effects could all be described by the 




For children, many of these services could be shared with specialized school 
officials. It has already been determined that pediatric brain tumors are the second leading 
cause of cancer (Lönnerblad et al., 2019). With this statistic in mind, there is certainly no 
lack of need for trained, specialized workers to handle this kind of care. School counselors 
could be informed when a child has been diagnosed, set them up for screening, therapy, 
appropriate testing, and work with the parents to ensure better educational outcomes and 
future prospects for pediatric brain tumor survivors. One such study, by Northman et al., 
describes a plan that includes “school-hospital liaisons” that help with home services, 
ensuring a more supportive environment at school with regard to neurocognitive deficits. 
In this model and in other proposed plans, the researchers advocate the importance of 
continued surveillance to more adequately address late effects, ensure rapid diagnosis at 
onset, begin application of the appropriate treatment, and see that testing is administered 
in a timely fashion. Another big push is for medical staff, school, caregiver, and social 
worker communication. This ensures all the relevant people involved in patient care are all 
on the same page, treatment decisions can be agreed upon, and swift action taken in decline 
(2015). 
 From a public health perspective, community initiatives specific to survivors could 
manage the support aspect of the survivor programs. Support groups, social determinants 
assessments based upon socioeconomic condition, life cycle position, risk factor groups 
etc. could be controlled by local public health offices. Resources, programming, education, 
pamphlets for late effects, and prevention services could also fall under the public health 
sphere and are among the ten essential services of public, under the assessment and policy 




many records and databases current with relevant health data. Utilizing an observation and 
surveillance system to track late effects, chronic conditions, and a survivor record system 
would be an effective measure. Further, a registry system would catch non-compliant 
patients and allow public health workers, primary care physicians, counselors, and social 
workers to slate this population for assistance and service access. For example, if 
transportation or economic decline are issues, these patients could utilize aid available 
through nonprofits and public health organizations to meet their needs and therefore be 
able to seek necessary treatment and testing.  
This kind of model would be more feasible in big healthcare systems or wealthier 
for-profit hospitals. However, it would be best if the bigger systems collaborate with 
smaller systems and hospitals, thereby bolstering some of the cost and sharing the work 
equally. This is easier said than done, and these registries would have to comply with 
HIPAA standards. Nevertheless, ensuring adequate record-keeping, utilizing national 
registries, and having a solid tracking system would help patients get the best possible 
continued care, no matter where care is received. At the end of the day, keeping patients 
up to date with checkups, screening, and follow-up is paramount. 
 External to the standardized model are extraneous factors that act as barriers to 
care, such as cost, health insurance, availability of providers, and employment concerns of 
patients. More should be done for hiring adequate numbers of counselors, navigators, 
trained oncology nurses, and social workers. For an integrated system to be set in place, 
organizations would have to be on board with appropriate headcount, hiring, and recruiting 




qualities of each of the programs was the broad access to a network of subspecialists and 
providers. If insurance is accepted, there is likely no issue going forward with care, as the 
network all fall under the same umbrella. However, this does not address the elephant in 
the room, which is the American Healthcare System as a whole. Not every American is 
covered, and even if there is a plan, the insurance company may not always agree to care 
and follow up. Also, many insurance plans are based on employer coverage. Throughout 
treatment and with future suffering of late effects, survivors may lose access to employer 
provided benefits, including insurance. Even if survivors are covered, the premiums, 
copays, coinsurance, cost of services not covered may be financially crippling.  
The proposed model would increase the number of visits and services utilized, but 
follow-up is a complex process. Though a large portion of this might be considered 
preventative care, in which case insurance may cover it, the boundaries and lines in the 
convoluted insurance system are blurred. The 2006 report addressed some of these 
concerns stating that Medicare can be an option for those over 65, but a large portion of 
the survivor population does not fall into that category. Within the report, there was a 
mention that an Institute of Medicine committee that addresses insurance pushed for 
Universal Healthcare in 2004, controlled costs for services, and increased funding to other 
programs that could provide coverage, such as COBRA (Consolidated Omnibus Budget 
Reconciliation Act). In the interim, continuous health care for cancer survivors is 
invaluable, and many of these interventions can be achieved through policy writing. 
Funneling federal money into high-risk pools was proposed, which would lower costs for 




criteria changing for breast and cervical cancer patients in 2000, but no such exception was 
made for brain neoplasm and other cancer survivors (National Research Council, 2006). 
The biggest takeaway from the literature review is that this is a multifaceted 
process. With more healthcare systems acknowledging the experience of the survivor and 
crafting plans to offer supportive care, there is likely no one size fits all model. Existing 
plans, such as those in the Pennsylvania health systems, are built upon current knowledge 
and research. Local health care systems are making concerted efforts, utilizing available 
resources, to provide their definition of quality care. It’s a step in the right direction. A six-
year survivor of malignant brain cancer, Michael Feuerstein, described his survivor care 
plan as a “living document” (2009). The process of defining a plan, staying on top of late 
effects, managing chronic conditions, integrating teams and providers, getting insurance 
on board is clearly a dynamic process. With advocacy and awareness, these themes can be 
explored further. Best practices can and should be continually reassessed, with new 
information and upgraded care plans displacing outdated archetypes.  
The survivorship model is a “simple and logical dimension of care,” but it’s easy 
for patients to feel lost when it comes to the long-term outcomes (Feuerstein, 2009). As 
new research is conducted surrounding survivor care models and quality, changes can and 
should be implemented aimed at alleviating patient and caregiver burden. Attempts should 
also be made at the policy level to provide a standardized version of care as a springboard 
to further the efficacy and patient perceived value of supportive care plans. Taken together, 
these endeavors would afford brain tumor survivors a safety net, some semblance of 




RECOMMENDATIONS FOR FUTURE STUDIES  
 Future recommended studies should investigate standardized care plans, costs, 
efficacy, and troubleshooting. These plans can be implemented or overhauled if solid 
research supports a better model of care. Additionally, the interplay between 
neurocognitive, psychosocial, and somatic late effects is only beginning to be expounded, 
and should be studied more thoroughly. More studies on adults should be performed, as 
much of the literature focused on children due to brain plasticity and likely due to readily 
available funding for pediatric research. Further, tracking of late effects to discover 
patterns and potential markers should be considered. Much of the literature could only 
speculate the causal relationship of late effects and assumed shared causation of treatment 
modality and the neoplasm pathology. Research to better understand these mechanisms 
would help providers and patients understand the direct implications of a specific 
treatment modality and the effects that could ensue. Responses in the education system 
for children are beginning to be studied, but more could be done. Also, further research 
concerning adult survivors in the workforce and complications surrounding late effects 
should be done.  
Public health interventions and community based survivor care models could also 
be researched. How best to disseminate information to patients, providers, and the public 
on long-term effects and survivorship is an important question. Also, determining what 
survivorship looks like in different stages of the life cycle, by zip code, in different ethnic 
backgrounds is a worthy goal. Information surrounding these topics is important to 




consideration. Cancer is a major public health concern, and it would behoove the public 
to be knowledgeable of these outcomes, as many will likely encounter what it means to 

































Alemany, M., Velasco, R., Simó, M., & Bruna, J. (2021). Late effects of cancer 
treatment: consequences for long-term brain cancer survivors. Neuro-Oncology 
Practice, 8(1), 18–30. https://doi.org/10.1093/nop/npaa039 
Alias, H., Lau, S. C. D., Schuitema, I., & de Sonneville, L. M. J. (2018). 
Neuropsychological consequences for survivors of childhood brain tumor in 
Malaysia. Frontiers in Psychology, 9. https://doi.org/10.3389/fpsyg.2018.00703 
Barakat, L. P., Li, Y., Hobbie, W. L., Ogle, S. K., Hardie, T., Volpe, E. M., Szabo, M. 
M., Reilly, M., & Deatrick, J. A. (2015). Health-related quality of life of 
adolescent and young adult survivors of childhood brain tumors. Psycho-
Oncology, 24(7), 804–811. https://doi.org/10.1002/pon.3649 
Boelhouwer, I. G., Vermeer, W., & van Vuuren, T. (2021). The associations between late 
effects of cancer treatment, work ability and job resources: a systematic 
review. International Archives of Occupational and Environmental Health, 94(2), 
147. https://doi.org/10.1007/s00420-020-01567-w 
Boydell, K. M. ( 1,2,6 ), Greenberg, M. ( 2,4 ), Stasiulis, E. ( 3 ), Spiegler, B. ( 3 ), & 
Greenberg, C. ( 5 ). (n.d.). I’ll show them: The social construction of 
(in)competence in survivors of childhood brain tumors. Journal of Pediatric 




Brain tumor patient support. (2021). https://www.pennmedicine.org/for-patients-and-
visitors/find-a-program-or-service/neurosurgery/brain-tumor-center/treatments-
and-procedures/brain-tumor-support-groups. 
Brand, J. (2021). Einstein healthcare network and jefferson health merger clears final 
hurdle. https://hospitals.jefferson.edu/news/2021/03/einstein-jefferson-health-
merger.html 
CDC/National Center for Health Statistics. (2021, March 1). FastStats - leading causes of 
death. https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm.  
CDC: Centers for Disease Control and Prevention. (2020). 10 Essential Health Services. 
Retrieved from: https://www.cdc.gov/publichealthgateway/publichealthservices/ 
essentialhealthservices.html 
Cousino, M., Hazen, R., Josie, K., Laschinger, K., de Blank, P., & Taylor, H. (2017). 
Childhood Cancer and Brain Tumor Late Effects: Relationships with Family 
Burden and Survivor Psychological Outcomes. Journal of Clinical Psychology in 
Medical Settings, 24(3/4), 279–288. https://doi.org/10.1007/s10880-017-9519-6 
de Ruiter, M. A., Schouten-van Meeteren, A. Y. N., van Vuurden, D. G., Maurice-Stam, 
H., Gidding, C., Beek, L. R., Granzen, B., Oosterlaan, J., & Grootenhuis, M. A. 
(2016). Psychosocial profile of pediatric brain tumor survivors with 
neurocognitive complaints. Quality of Life Research: An International Journal of 




of the International Society of Quality of Life Research, 25(2), 435. 
https://doi.org/10.1007/s11136-015-1091-7 
Erdmann, F., Frederiksen, L. E., Bonaventure, A., Mader, L., Hasle, H., Robison, L. L., 
& Winther, J. F. (2021). Childhood cancer: Survival, treatment modalities, late 
effects and improvements over time. Cancer Epidemiology, 71(Part B). 
https://doi.org/10.1016/j.canep.2020.101733 
Feuerstein M. (2009). The cancer survivorship care plan: health care in the context of 
cancer. Journal of oncology practice, 5(3), 113–115. 
https://doi.org/10.1200/JOP.0934406 
Heather Leeper, Kathrin Milbury, Survivorship care planning and implementation in 
neuro-oncology, Neuro-Oncology, Volume 20, Issue suppl_7, November 2018, 
Pages vii40–vii46, https://doi.org/10.1093/neuonc/noy110 
Institute of Medicine and National Research Council. 2006. From Cancer Patient to 
Cancer Survivor: Lost in Transition. Washington, DC: The National Academies 
Press. https://doi.org/10.17226/11468. 
Janss, A. J., Mazewski, C., & Patterson, B. (2019). Guidelines for Treatment and 
Monitoring of Adult Survivors of Pediatric Brain Tumors. Current Treatment 
Options in Oncology, 20(1), 10. https://doi.org/10.1007/s11864-019-0602-0 





Jefferson university hospitals. (2021). https://hospitals.jefferson.edu/departments-and-
services 
LiveWell survivorship program. (n.d.). Hillman Cancer Center. https://hillman. 
upmc.com/patients/community-support/livewell-survivorship 
Lönnerblad, M., Berglund, E., van’t Hooft, I., & Blomgren, K.. (n.d.). A nationwide, 
population-based study of school grades, delayed graduation, and qualification for 
school years 10-12, in children with brain tumors in Sweden. Pediatric Blood and 
Cancer, 67(2). https://doi.org/10.1002/pbc.28014 
Maciel, J., Dias, D., Cavaco, D., Donato, S., Pereira, M. C., & Simões-Pereira, J. (2021). 
Growth hormone deficiency and other endocrinopathies after childhood brain 
tumors: results from a close follow-up in a cohort of 242 patients. Journal of 
Endocrinological Investigation: Official Journal of Italian Society of 
Endocrinology (SIE), 1. https://doi.org/10.1007/s40618-021-01541-4 
Mellblom, A. V., Kiserud, C. E., Rueegg, C. S., Ruud, E., Loge, J. H., Fosså, S. D., & 
Lie, H. C. (2021). Self-reported late effects and long-term follow-up care among 
1889 long-term Norwegian Childhood, Adolescent, and Young Adult Cancer 
Survivors (the NOR-CAYACS study). Supportive Care in Cancer, 29(6), 2947. 
https://doi.org/10.1007/s00520-020-05790-6 
Northman, L., Ross, S., Morris, M., & Tarquini, S. (2015). Supporting pediatric cancer 
survivors with neurocognitive late effects: A model of care. Journal of Pediatric 




Patient & family support for cancer - Jefferson university 
hospitals. (2020). https://hospitals.jefferson.edu/departments-and-services/sidney-
kimmel-cancer-center/patient-and-family-support.html 
Quick Brain Tumor Facts. National Brain Tumor Society. (2021). 
https://braintumor.org/brain-tumor-information/brain-tumor-facts/.  
Ramanauskienė, E., Labanauskas, L., Verkauskienė, R., & Šileikienė, R. (2014). Early 
development of endocrine and metabolic consequences after treatment of central 
nervous system tumors in children. Medicina, 50(5), 275–280. 
https://doi.org/10.1016/j.medici.2014.10.006 
Robinson, K. E., Pearson, M. M., Cannistraci, C. J., Anderson, A. W., Kuttesch, J. F., 
Wymer, K., Smith, S. E., Park, S., & Compas, B. E. (2015). Functional 
neuroimaging of working memory in survivors of childhood brain tumors and 
healthy children: Associations with coping and psychosocial outcomes. Child 
Neuropsychology, 21(6), 779–802. 
https://doi.org/10.1080/09297049.2014.924492 
Satariano, S. (2016). The “late effects” of paediatric brain tumours and the implications 
for education settings. Educational & Child Psychology, 33(1), 20–33. 
Shabason, E. K., Brodsky, C., Baran, J., Isaac, L., Minturn, J. E., Ginsberg, J. P., Hobbie, 
W., Fisher, M., Blum, N., & Hocking, M. C. (2019). Clinical diagnosis of 




tumors. Journal of Neuro-Oncology, 143(2), 305–312. 
https://doi.org/10.1007/s11060-019-03165-4 
Support and resources. (n.d.). https://hospitals.jefferson.edu/departments-and-
services/vickie-and-jack-farber-institute-for-neuroscience/programs/brain-tumor-
care/support-and-resources.html 
Supportive care for cancer survivors begins at diagnosis. (n.d.). 
https://sidneykimmelcancercenter.jeffersonhealth.org/?article=2020-Supportive-
Care-Services-Cancer-Survivors 
Survivorship program. (2021). https://www.pennmedicine.org/cancer/navigating-cancer-
care/programs-and-centers/survivorship 
U.S. News & World Report. (2020). U.S. news releases 2020-21 best hospitals rankings 




U.S. News & World Report. (2021). Best hospitals for neurology & 
neurosurgery. https://health.usnews.com/best-hospitals/rankings/neurology-and-
neurosurgery 
United States Census Bureau. (2019). QuickFacts: Philadelphia city, Pennsylvania; 





Winter, A. L., Conklin, H. M., Tyc, V. L., Stancel, H., Hinds, P. S., Hudson, M. M., & 
Kahalley, L. S. (2014). Executive function late effects in survivors of pediatric 
brain tumors and acute lymphoblastic leukemia. Journal of Clinical & 




































Appendix A. An Example of Survivorship Care - An Integrated Process Flow Map for a 
Plausible Model of Quality Care (Leeper, Milbury, 2018). 
